The Science and the Law of Toxics

This presentation is based on a larger book project I am undertaking with Tom McGarity entitled “Bending Science” (forthcoming Harvard U. Press 2008).

See, e.g., Blumenstyke Goldie , The Price of Research: A Berkeley Scientists Says a Corporate Sponsor Tried to Bury his Unwelcome Findings and Then Buy his Silence, THE CHRONICLE, Oct. 31, 2003.

Renner Rebecca , Conflict Brewing over Herbicide's Link to Frog Deformities, 298 SCIENCE 938 (2002).

Environmental Protections Agency, Report of FIFRA Scientific Advisory Panel Meeting on the Potential Developmental Effects of Atrazine on Amphibians, June 17–20, 2003, p 17–19, available at <http://www.epa.gov/scipoly/sap/meetings/2003/june/junemeetingreport.pdf>.

In re Silica Prods. Liab Litig., 398 F. Supp. 2d 563 (S.D. Tex. 2005).

Bekelman Justin E. Li Yan & Gross Cary P. , Scope and Impact of Financial Conflicts of Interest in Biomedical Research, 289 JAMA 454 (2003).

Lutz Frank , “Straight Talk, The Environment: A Cleaner, Safer, Healthier America,” (undated) 137–38, <www.luntzspeak.com/graphics/LuntzResearch.Memo.pdf>.

Needleman Herbert L. , Salem Comes to the National Institute of Health: Notes From Inside the Crucible of Scientific Integrity, 90 PEDIATRICS 977 (1992).

Fischer Paul M. , Science and Subpoenas: When Do the Courts Become Instruments of Manipulation? 59 Law & Contemporary Problems 159, 159 (1996).

Kennedy Donald , Prologue, in Steinzor Rena & Wagner Wendy , eds., Rescuing Science from Politics vi ( Wagner Wendy & Steinzor Rena , eds. 2006).

Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).

Siharath v. Sandoz Pharmaceuticals. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001), aff'd sub nom. Rider v. Sandoz Pharmaceuticals. Corp., 295 F.3d 1194 (11th Cir. 2002).